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A precipitating factor in the development of atherosclerotic lesions i s  the inappro- 
priate migration and proliferation of vascular smooth muscle cells (SMC) within 
the intima of the vessel wall. Focusing on the role of extracellular matrix proteins 
in SMC migration, we have demonstrated that thrombospondin (TSP) itself is a 
potent modulator of SMC motility and acts to potentiate platelet-derived growth 
factor (PDGF)-mediated SMC migration as well. Migration of SMC to TSP was 
dose dependent. Interestingly, maximal SMC migration to TSP exceeded that to 
either PDGF or basic fibroblast growth factor (bFGF). The distal COOH terminus 
of TSP was shown to mediate SMC migration a5 demonstrated by complete inhibi- 
tion of the response by monoclonal antibody (mAb) C6.7. Nevertheless, prote- 
olytic fragments of TSP were not as potent as intact TSP in mediating SMC migra- 
tion. Only by combining the heparin-binding domain (HBU) with the 140 kD 
COOH terminal fragment was SMC migration restored to levels seen with intact 
TSP. Based on antibody inhibition studies, an a,-containing integrin receptor, but 
not LY$, or a,P+, appeared to be involved in SMC migration to TSP. The coinci- 
dental expression of PDGF and TSP at sites of vascular injury and inflammation led 
us to evaluate the effect of suboptimal levels of TSP on SMC responsiveness to 
PDCF. SMC migration in response to PDGF was enhanced nearly 60% in the 
presence of suboptimal concentrations of TSP. This effect was specific for PDGF 
and dependent on the concentration of TSP with maximal potentiation obtaincd 
between 50-1 00 n M  TSP, concentrations tenfold lower than those necessary for 
SMC migration to TSP itself. mAb C6.7 complctely inhibited enhancement but, as 
with SMC migration to TSP alone, TSP proteolytic fragments did not po 
effectiveness of the intact molecule. Additional experiments assessing SM 
tion to PDGF demonstrated that PDGF stimulated SMC motility indirectly by 
inducing TSP synthesis. These studies suggested that TSP functions as an autocrine 
motility factor to modulate SMC migration, which in conjunction with PDGF 
could serve to aaaravate and accelerate development of atherosclerotic lesions at 
"I, 
sites of vascular injury or inflammation. 
M ig ra t i on  o f  smooth muscle cells (SMC) i n t o  the  vas- 
cular intima and t h e i r  inappropr iate p ro l i fe ra t ion  are  
thought  t o  contr ibute t o  the  pathology o f  atherosclero- 
sis (Ross, 1986). These func t iona l  changes correlate 
w i t h  the  modu la t ion  o f  t h e  SMC phenotype from a qui- 
escent, contracti le state t o  a synthetic, p ro l i fe ra t i ve  
state (Chamley-Campbell  e t  al., 1981). Therefore, t he  
signals that s t imu la te  SMC m i g r a t i o n  and prol i fera- 
t i on  have been intensively studied in order t o  ident i f y  
relevant pathways and possible nodes o f  intervent ion.  
One o f  t he  most poten t  modulators of SMC migra t i on  
and prol i ferat ion i s  platelet-der ived g r o w t h  factor 
(PDGF) (Ross e t  al., 1986). PDGF i s  secreted by acti-  
vated platelets and macrophages, among several o ther  
cel l  types, a t  sites of i n f l a m m a t i o n  and vascular dam- 
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age. Pro l i fe ra t ion  o f  quiescent SMC is  st imulated 
w i t h i n  24 hours  af ter  exposure t o  PDGF (Majack e t  al., 
1990). S imi la r ly ,  SMC migra t i on  to  PDGF has  been 
demonstrated in v i t r o  and, in vivo, PDGF i s  bel ieved to  
mediate SMC mig ra t i on  i n t o  the  neo in t ima (Groten- 
dorst e t  al., 1982; Clowes and Clowes, 1986). Overal l ,  
these profound effects o n  SMC physiology impl icate 
PDGF as a major  factor in the  propagat ion o f  athero- 
sclerotic lesions. 
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Less well studied is the involvement of extracellular 
matrix (ECM) molecules in SMC behavior. While SMC 
adhere to ECM components such as fibronectin, colla- 
gen, thrombospondin (TSP), and laminin, less is known 
about the role of ECM in SMC proliferation and migra- 
tion (Hedin et al., 1988; Lawler et al., 1988). Recent 
reports have demonstrated migration of SMC to fibrin- 
ogen and vitronectin, two ECM molecules that are 
abundant in plasma (Naito et al., 1989, 1991). In addi- 
tion, immunohistochemical analysis has localized high 
concentrations of fibronectin, collagen, and TSP at sites 
of atherosclerotic lesions and vascular injury (Raugi et 
al., 1990; Shekhonin et al., 1987) suggesting that, in 
vivo, these ECM components are localized in regions of 
active SMC proliferation and migration. 
TSP is unique among ECM proteins in that its con- 
centration in the plasma is fairly low. However, TSP 
expression increases rapidly and transiently following 
tissue damage and platelet activation (Mosher, 1990; 
Lawler, 1986). Besides platelets, TSP is also secreted by 
SMC, monocytes, endothelial cells, and fibroblasts. 
Within 30 minutes of PDGF stimulation TSP mRNA 
levels in SMC rise dramatically followed by an increase 
in protein levels within 2 hours (Majack et al., 1985, 
1987). The kinetics of TSP mRNA induction and its 
independence of protein synthesis suggested that TSP 
is a member of the immediate-early response gene fam- 
ily whose members include fos and myc. The ability of 
TSP to  modulate SMC proliferation, essentially acting 
as an autocrine growth factor for SMC, was demon- 
strated in two respects. First, TSP potentiates epider- 
mal growth factor (EGFbdependent mitogenesis (Ma- 
jack et al., 1986). Second, TSP was shown to be 
essential for the proliferative response of SMC to PDGF 
(Majack et al., 1988). These studies demonstrate that 
TSP is an important modulator of SMC function, and 
through its restricted pattern of expression in damaged 
tissue, may play a role in the progression of atheroscle- 
rotic lesions. 
We have investigated the effect of TSP on SMC motil- 
ity and have found TSP to be a potent stimulator of 
SMC migration. Additionally, we found that PDGF and 
TSP acted synergistically in stimulating migration. 
These data highlight not only the complex interactions 
between cells and extracellular signals involved in 
SMC physiology, but also suggest that the role of ECM 
proteins may be more integrative than previously real- 
ized. 
MATERIALS AND METHODS 
Materials 
TSP and TSP fragments were isolated and purified 
from activated platelets as  previously described (Dixit 
et al., 1984; Yabkowitz and Dixit, 1991). Platelet TSP is 
thought to be a TSPl homotrimer (LaBell et al., 1992). 
The 70 kD core fragment of TSP was produced by chy- 
motrypsin cleavage of the 140 kD fragment (1:lOO wtl 
wt) in the presence of 5 mM ethylenediaminetetraace- 
tic acid (EDTA) for 2 hours at 37°C followed by 
fractionation over a heparin-Sepharose column. The 70 
kD fragment was recovered in the flowthrough frac- 
tions. Intact TSP was also chymotrypsinized (1:100, wtl 
wt) for 40 minutes at 37°C and used without further 
fractionation (Mansfield et al., 1990). Homogeneity of 
TSP and TSP fragments was judged by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE) analysis to be >95c?. Human PDGF-BB and 
bFGF were generous gifts from Amgen (Thousand 
Oaks, CA) and Synergen (Boulder, CO), respectively. 
TSP-specific monoclonal antibodies (mAbs) have been 
previously described and characterized (Dixit et al., 
1986). The synthetic peptides GRGDS and GRGES 
were purchased from Calbiochem (La Jolla, CAI and 
Penninsula Labs (Belmont, CA), respectively, and were 
tested a t  a concentration of 1 mM. Heparin was pur- 
chased from Sigma (St. Louis, MO). Mouse IgG was 
purchased from Cappel (Malvern, PA) and used at a 
concentration of 20 pg/ml. Antibodies against cell sur- 
face receptors were obtained as follows: mAbs LM142 
and LM609 (both used at a dilution of 1:5) were gifts of 
Dr. David Cheresh (Scripps Clinic, La Jolla, CA); mAb 
AIIB2 specific for the PI integrin subunit (used at  a 1:5 
dilution) was a gift of Dr. Caroline Damsky (University 
of California, San Francisco, CA); mAbs SZ21 specific 
for the P3 integrin subunit and FA6.152 specific for 
GPIV (both used at  20 pgiml) were purchased from 
AMAC (Westbrook, ME); mAb 30 specific for GPIV 
(used a t  5 pgiml) was a gift of Dr. Graham Jamieson 
(American Red Cross, Rockville, MD); mAb OKM5 also 
specific for GPIV (used a t  5 pg/ml) was purchased from 
Ortho Diagnostics (Raritan, NJ). 
Cells 
Bovine pulmonary artery SMC were isolated and 
characterized as described (Ryan and Maxwell, 1992) 
and used between passages 2 and 10. Cells were grown 
in Dulbecco’s modified eagle’s medium (DMEM) con- 
taining 10% fetal bovine serum (FBS), nonessential 
amino acids, 1 mM sodium pyruvate, 100 Uiml penicil- 
lin, 100 pgiml streptomycin, and 250 pgiml gentami- 
cin. Confluent SMC were subcultured at  1:3 or 1:4 as 
needed. SMC were harvested a t  80% confluency by in- 
cubation in phosphate-buffered saline (PBS) containing 
1 mM EDTA for 3 minutes followed by pipetting cells 
off the plates. Pooled cells were washed three times in 
DMEM and allowed to recover for 30 minutes a t  room 
temperature before treatment. 
Chemotaxis assays 
Assays were carried out in 48-well chambers (Neuro- 
probe, Cabin John, MD) using 8 km polycarbonate fil- 
ters (Nuclepore, Pleasanton, CA) essentially as de- 
scribed (Mansfield et al., 1990; Yabkowitz et al., 1993). 
Filters were soaked overnight in 100 p.g/ml gelatin in 
0.1% acetic acid a t  37°C to allow the initial attachment 
of cells (Taraboletti et al., 1987). TSP, TSP fragments, 
or growth factors were diluted in DMEM plus 0.1% 
bovine serum albumin (BSA) and added to the lower 
wells of the chamber. SMC (3 x 104/well) in the same 
buffer were added to the upper well of the chamber and 
the assembled chamber incubated for 6 hours a t  37°C. 
Filters were fixed and stained with hematoxylin. Three 
filters were used for each treatment and five fields 
were scored from each filter under high power magnifi- 
cation ( ~ 4 0 0 ) .  Data were expressed as mean number 
SMC migrating per field 2 S.E.M. Buffer alone in the 
lower well served as a negative control (0.5 5 0.3 SMC/ 
field). Where appropriate, statistical analysis for sig- 
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nificance was performed using a one-tailed paired Stu- 
dent's t-test. For inhibition experiments, TSP was 
preincubated with anti-TSP mAbs for 30 minutes a t  
37"C, or SMC were preincubated with mAbs against 
cell surface receptors or synthetic peptides for 30 min- 
utes a t  room temperature before being added to the 
lower or upper wells of the chamber, respectively. In  
experiments where chemoattractants were combined, 
no preincubation was necessary; the individual compo- 
nents were added directly to  the lower wells. For cyclo- 
heximide and mAb C6.7 experiments, SMC were prein- 
cubated for 16 hours or 30 minutes, respectively, before 
addition to the upper wells of chemotaxis chambers. 
Cycloheximide (10 pglml) or mAb C6.7 was also present 
throughout the assay period. Treated SMC were evalu- 
ated for chemotaxis to either 10 nglml PDGF or 1 pM 
TSP as described above. All experiments were repeated 
two to three times. 
RESULTS 
SMC chemotaxis to TSP 
Pulmonary artery SMC demonstrated dose-depen- 
dent migration to soluble TSP with a linear increase 
between 30 and 200 nM TSP and a maximal response 
seen a t  approximately 1 FM (Fig. la). Directionality of 
migration (chemotaxis) was established by comparing 
the response of SMC to TSP placed in either the upper 
or lower wells; whereas SMC migration to TSP placed 
in the lower wells was significant, no migration above 
background was evident when TSP was present in the 
upper wells (data not shown). We compared the re- 
sponse of SMC to TSP to the responses of SMC to two 
other well characterized chemoattractants, PDGF-BB 
and bFGF (Grotendorst et al., 1982; Sat0 et al., 1991). 
At their maximal effective concentrations, TSP, on av- 
erage, elicited a 40% higher response than either PDGF 
or bFGF (Fig. lb) .  
To rule out the possibility that transforming growth 
factor beta (TGF-p) contamination of our TSP prepara- 
tions was responsible for the migratory effects observed 
with SMC (Murphy-Ullrich et al., 1992), we used both a 
neutralizing anti-TGF-p antibody and purified recom- 
binant TGF-p. In one set of assays, TSP was preincu- 
bated with varying concentrations of anti-TGF-@ anti- 
body (up to 100 pg/ml) before addition to the lower 
wells of chemotaxis chambers. No effect on SMC chemo- 
taxis to TSP was observed over the range of antibody 
concentrations tested (data not shown). Additionally, 
spiking our TSP preparations with 0.01-100 ng/ml re- 
combinant TGF-p did not alter SMC chemotaxis to TSP 
(data not shown). These results indicated that  TSP- 
mediated SMC chemotaxis was not a result of TGF-P 
contamination, but represented a TSP-specific re- 
sponse. 
To further demonstrate specificity and determine 
which domain of the TSP molecule mediated SMC mi- 
gration, anti-TSP mAbs were screened for inhibition of 
migration. mAb C6.7, specific for the distal COOH ter- 
minus, inhibited SMC migration to TSP (Fig. 2). None 
of the other mAbs tested, including mAb A2.5 directed 
against the heparin-binding domain (HBD), inhibited 
SMC migration. Interestingly, heparin inhibited SMC 
migration slightly, by approximately 20%. In contrast, 
another sulfated oligosaccharide, dermatan sulfate, did 
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Fig. 1. TSP mediates calf pulmonary artery SMC migration. a: SMC 
migration to TSP is dose dependent. b: Comparison of SMC migration 
to PDGF, bFGF, and TSP. SMC (3 x 104/well) were placed into the 
upper wells of modified Boyden chambers and the indicated concentra- 
tions of TSP, PDGF, or bFGF were added to the lower wells. Assays 
were carried out for 6 hours at  37°C. The number of migrating SMC 
was scored as described in Materials and Methods with triplicate fil- 
ters prepared for each concentration. Five high power ( ~ 4 0 0 )  fields 
were scored for each filter and values shown represent the 
mean ? S.E.M. The number of migrating cells/field was comparable 
between triplicate filters in any experiment. For example, the range of 
SMC migration to 1 pM TSP was 54-72,53-71, and 59-74 SMCifield 
in the triplicate filters assayed in a single experiment. SMC responses 
to PDGF-BB, bFGF, or TSP were compared a t  the concentration deter- 
mined to elicit maximal SMC migration in each case; specifically 0.3 
nM (10 ngiml) PDGF, 0.6 nM (10 ngiml) bFGF, or 1 KM TSP. 
not inhibit SMC migration (data not shown). Mouse 
IgG had no effect (data not shown). Inhibition of migra- 
tion by mAb C6.7 was dose dependent with partial inhi- 
bition evident at 50 kglml antibody and virtually com- 
plete inhibition a t  200 pglml (Table 1). 
To further define the TSP domain(s) involved in me- 
diating SMC chemotaxis, assays were also conducted 
with TSP proteolytic fragments. Surprisingly, no prote- 
olytic fragment retained the potency of intact TSP in 
mediating SMC migration (Fig. 3). The 140 kD frag- 
ment (140K), containing the mAb C6.7 epitope, par- 
tially supported SMC chemotaxis with a maximal re- 
sponse approximately 50% of that seen with intact TSP. 
SMC migration to 140K was dose dependent, similar to 
that observed with intact TSP, with a maximal effect 
observed at 1 FM (data not shown). Both the HBD and 
the 70 kD core region, derived from the 140 kD frag- 
ment, supported a minimal level of SMC migration, a t  
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Fig. 2. Migration of SMC to TSP is inhibited by anti-TSP mAb C6.7. 
TSP (1 KM) was preincubated in the presence or absence of anti-TSP 
mAbs (200 Fgiml) or heparin (100 Fgiml) for 30 minutes a t  37°C before 
being placed in the lower wells of modified Boyden chambers. SMC 
(3 x 104/well) were placed in the upper wells and the assay carried out 
for 6 hours at  37°C. The number of migrating SMC was scored as 
described in Materials and Methods with triplicate filters prepared for 
each treatment. Five high power (X400) fields were scored for each 
filter and values shown represent the mean ? S.E.M. *P < 0.01. 
TABLE 1. Inhibition of SMC chemotaxis to TSP by mAb C6.7 is 
dose dependent 
mAb concentration 
- Treatment ( wgiml) 
Buffer - 
TSP - 
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'TSP (1 wMl was preincubated In the presence or absence of the indicated concentra- 
tions of mAh CG 7 for 30 minutes at 37°C before being placed into the lower wells of a 
modified Boyden chamber. SMC (3 x 10') were placed in each upper well and the assay 
carried out for G hours at 37°C. The number ofmigrating SMC was scored as described in 
Materials and Methods with triplicate filters prepared for each treatment. Five high 
power (x4001 fields were scored for each filter and values shown represent the mean t 
S.E.M. 
most 10% of the response to intact TSP. In contrast, the 
combination of the HBD and 140K was almost as  potent 
as intact TSP (Fig. 3). The chemotactic response was 
significantly greater (P < 0.05) than the calculated ad- 
ditive effect of the HBD and 140K individually. Al- 
though the HBD itself was relatively ineffective in sup- 
porting SMC migration, it appeared to enhance SMC 
migration to 140K. This enhanced response was consis- 
tently observed among several different batches of both 
the HBD and 140K. 
SMC chemotaxis to 140K and the combination of 
140K and the HBD was further evaluated in the pres- 
ence of anti-TSP mAbs (Table 2). mAb C6.7 inhibited 
migration of SMC to either 140K or the HBDA40K 
mixture by approximately 50%. Interestingly, heparin 
inhibited SMC migration to either 140K or the HBD/ 
140K mixture equivalently, by about 2096, suggesting 
that heparin may be interacting with a site on 140K. 
This possibility was confirmed by assessing SMC mi- 
gration in the presence of both heparin and mAb C6.7; 
in the presence of both reagents, SMC migration to 
140K 
HBD 
140K + HBD 
Chymotryp. TSP 
70 kD wre 
0 10 20 30 40 50 60 
# SMC Migrating1400X Field 
Fig. 3. Migration of SMC is partially supported by TSP proteolytic 
fragments but fully restored by a combination of the HBD and 140K. 
SMC (3  x 104/well) were placed into the upper wells of modified Boy- 
den chambers. TSP or TSP proteolytic fragments (1 (LM) were added to 
the lower wells and assays carried out for 6 hours at 37°C. The number 
of migrating SMC was scored as described in Materials and Methods 
with triplicate filters prepared for each treatment. Five high power 
( x  400) fields were scored for each filter and values shown represent 
the mean -t S.E.M. *P < 0.05, migration of SMC in response to a mix- 
ture of the HBD and 140K was compared to SMC migration in re- 
sponse to the calculated additive effect of the fragments individually. 
either 140K or the HBD/140K mixture decreased to 
nearly background levels, thereby suggesting that co- 
operative interactions between two sites on TSP may be 
involved. Furthermore, mAb A2.5 did not inhibit SMC 
migration to the HBD/140K mixture, reinforcing the 
likelihood that a heparin-binding site within 140K was 
involved. Thus, the priming effect of the HBD on SMC 
chemotaxis to 140K may involve conformational 
changes in the 140 kD domain driven by its interaction 
with the HBD. 
SMC receptors involved in 
TSP-mediated chemotaxis 
Several distinct cell surface molecules, including 
a,ps integrins and GPIV (CD36), have been shown to 
serve as TSP receptors on a variety of cell types (Lawler 
et al., 1988; Asch et  al., 1987). We, therefore, tested 
antibodies to these molecules to determine whether 
these receptors mediated the migration of SMC to TSP. 
MAb LM142, specific for the a, subunit of the a,p3 
vitronectin receptor (Cheresh and Spiro, 1987), par- 
tially inhibited SMC migration (Fig. 4). At 200 pgiml 
mAb LM142 inhibited migration by about 60% 
(P < 0.05). Interestingly, the same concentration of 
mAb LM609, specific for the avp3 complex (Cheresh 
and Spiro, 1987), did not significantly inhibit migra- 
tion. In contrast, SMC chemotaxis to 1 pM vitronectin 
(15.8 2 1.0 SMC/field) was reduced by 70% (4.7 ? 0.6 
SMC/field) in the presence of 200 pg/ml mAb LM609. 
These data suggested that the a, subunit was mediat- 
ing SMC migration through its association with an al- 
ternative p subunit. However, antibodies to the and 
p3 subunits did not significantly inhibit migration. Ad- 
ditionally, the synthetic peptides GRGDS and GRGES 
failed to significantly inhibit SMC migration, indicat- 
ing that the RGD amino acid sequence in TSP was not 
involved in SMC migration to TSP. Similarly, three 
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TABLE 2. Inhibition of SMC migration to TSP fragments 
Attractant Inhibitor Concentration '% Control (+SEMI 
140K None - 100.0' 
mAb C6.7 100 pgiml 47.6 (25.1) 
mAb A2.5 100 kgiml 109.4 ik3.9) 
Heparin 100 pglml 86.0 (512.11 
6.0 (k6.5) mAb C6.7 + heparin 
mAb C6.7 100 pgiml 56.1 i i9 .3)  
mAb A6.1 100 Fgiml 109.6 ( 2 5 . 2 )  
100 pgiml each 
140K + IIBD None - 100.0 
mAb A2.5 100 Kglrnl 108.2 (t-1.8) 
mAb C6.7 + heparin 
Heparin 100 pgiml 81.8 (28.91 
7.8 ( t 1 .Ol 100 pg/ml each 
'140K ur 140K + IIBD (1 pM) were preincuhakd with the indicated concentrations of mAbs or heparin for 30 minutes at 37°C 
beforc being placcd into thc lower wells of a modified Buyden chamber. SMC ( 3  X 104/wellJ were placed into lhe upper wells and 
the assay carried out  for 6 hours at 37°C. The number of migrating SMC was scored as described in Materials and Methods with 
triplicate filters prepared tor each treatment Five high power ( ~ 4 0 0 ,  fields were scored for each filter and values shown 
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Fig. 4. SMC migration to TSP is inhibited by antibodies to  the 01, 
subunit of integrin receptors. SMC (3 x 104/well) were preincubated 
in the presence or absence of the indicated antibodies, mouse IgG, or 
the synthetic peptides GRGDS or GRGES for 30 minutes at  room 
temperature before being added to the upper wells of modified Boyden 
chambers. TSP (1 pM) was present in the lower wells of all samples. 
Migration assays were carried out for 6 hours at 37°C. The number of 
migrating SMC was scored as described in Materials and Methods 
with triplicate filters prepared for each treatment. Five high power 
(x400)  fields were scored for each filter and values shown represent 
the mean % control -t S.E.M. Control samples represented SMC mi- 
gration to l pM TSP in the absence of' antibody and averaged 
56.8 ? 2.1 SMCI400x field. :!'P << 0.05. n.s. = not significant. 
different mAbs directed against GPIV had no effect on 
SMC migration. These results revealed that the 01, inte- 
grin subunit associated with a f3 subunit other than PI 
or PB is important in the migratory response of SMC to 
TSP. Furthermore, the lack of complete inhibition by 01, 
specific antibodies suggested that  another SMC recep- 
tor may also be involved in mediating SMC migration 
to TSP. 
TSP potentiates PDGF-mediated 
SMC chemotaxis 
TSP mRNA levels increase within 30 minutes of 
PDGF stimulation of SMC and, subsequently, TSP ex- 
pression increases within 2 hours (Majack et al., 1985, 
1987). Therefore, within this short time frame after 
Attractant -
1 
50 nM TSP 
I 
* I PDGF+BO nM TSP 
bFGF+SO nM TSP 
0 10 20 30 40 50 60 70 80 90 100 
# SMC Migratind400X Field 
Fig. 5. TSP potentiates SMC migration to PDGP. SMC 13 x lo'lwell) 
were placed in the upper wells of modified Boyden chambers. PDGF 
(10 ngiml), bFGF (10 ngiml), TSP (50 nM), or a mixture of TSP and 
either PDGF or bFGF was placed into the lower wells and SMC migra- 
tion allowed to proceed for 6 hours a t  37°C. The number of migrating 
SMC was scored as described in Materials and Methods with triplicate 
filters prepared for each treatment. Five high power (x400)  fields 
were scored for each filter and values shown represent the mean i- 
S.E.M. '2P <: 0.025, migration of SMC in response to a mixture of 
PDGF and 50 nM TSP was compared to SMC migration in response to 
the calculated additive effect of each attractant individually. 
PDGF stimulation, the extracellular environment con- 
tains both PDGF and TSP; each of which can stimulate 
SMC migration. It was therefore of interest to deter- 
mine whether PDGF and TSP together would affect 
SMC migration differently than either molecule alone. 
In the presence of suboptimal concentrations of TSP, 
SMC motility to PDGF was increased significantly, 
P < 0.025, above the calculated additive response of 
SMC to each attractant individually (Fig. 5 ) .  This effect 
was specific for PDGF, since the addition of suboptimal 
concentrations of TSP to bFGF did not elicit similar 
potentiation. The enhancing effect of' TSP on PDGF- 
mediated migration was consistent among different 
batches of TSP and PDGF. Furthermore, the potentia- 
tion of SMC motility was dependent on TSP concentra- 
tion (Fig. 6), with the extent of potentiation increasing 
as the concentration of TSP increased. In the presence 
of 50 nM TSP SMC migration was about 50% higher 
than the calculated additive response of SMC to each 
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Fig. 6.  TSP potentiation of SMC migration to PDGF is dose depen- 
dent. SMC (3 x 104/well) were placed in the upper wells of modified 
Boyden chambers. PDGF (10 ng/ml) and the indicated concentrations 
of TSP were combined and placed into the lower wells. SMC migration 
was allowed to proceed for 6 hours a t  37°C. The number of migrating 
SMC was scored as described in Materials and Methods with triplicate 
filters prepared for each treatment. Five high power (X400)  fields 
were scored for each filter and values shown represent the mean ratio 
of experimental to control SMC migration. Control migration repre- 
sents the calculated additive effect of PDGF and TSP assayed individ- 
ually, with the fraction due to PDGF and TSP (0 )  indicated. Exper- 
imental migration represents the observed effect on SMC migration of 
the mixture of PDGF and TSP together. The fraction of the response to 
the mixture of PDGF and TSP accounting for the potentiation effect of 
TSP is indicated IEJ ). 
attractant. Peak enhancement of PDGF-mediated mi- 
gration was seen at 100 nM TSP, approximately a 60% 
increase, with higher concentrations of TSP inducing 
less of a response. Overall, SMC migration to the com- 
bination of PDGF and TSP was greater than migration 
to either 10 ng/ml PDGF or 1 pM TSP, concentrations 
that yielded maximal migration. 
As with SMC migration to TSP alone, anti-TSP mAbs 
were used to determine which domain of TSP mediated 
the enhancement of PDGF-mediated SMC migration 
(Fig. 7a). In the presence of 75 pg/ml mAb C6.7 motility 
decreased by about 80%; at  200 pg/ml mAb C6.7 the 
response was completely abolished. The ability of mAb 
C6.7 to completely inhibit migration to the combina- 
tion of 50 nM TSP and PDGF was surprising, consider- 
ing that PDGF is typically a strong stimulus for SMC 
migration, and suggested that specific interactions be- 
tween the two molecules might be responsible. Other- 
wise, an antibody against TSP would not be capable of 
knocking out the response to PDGF as  well. None of the 
other TSP-specific mAbs were inhibitory. 
Since the 140 kD fragment of TSP partially sup- 
ported SMC migration, we evaluated its effectiveness 
at suboptimal concentrations in potentiating migration 
to PDGF (Fig. 7b). Neither 140K nor the HBD potenti- 
ated SMC migration above the calculated additive re- 
sponse. Based on the evidence that the HBD enhanced 
SMC migration to 140K, we also looked at whether a 
combination of the HBD and 140K would potentiate 
SMC migration to PDGF. This was not the case; indeed 
the migratory responses to the combination of PDGF, 
140K, and the HBD were similar to the responses ob- 
served with PDGF and either fragment alone. Thus, it 
appeared that potentiation of SMC migration to PDGF 
mediated by suboptimal concentrations of TSP could 
only be elicited by intact TSP. 
Complete inhibition by mAb C6.7 of SMC chemotaxis 
to the combination of 50 nM TSP and PDGF suggested 
that PDGF indirectly stimulated SMC motility, per- 
haps by inducing TSP synthesis. Thus, TSP could func- 
tion as  an autocrine motility factor for SMC. In order to 
establish whether this mechanism was feasible, we as- 
sessed PDGF-mediated motility in the presence of ei- 
ther mAb C6.7 or cycloheximide. SMC preincubated 
with mAb C6.7 were unable to migrate in response to 
PDGF (Fig. 8a). Inhibition was dose dependent with 
migration reduced to background levels in the presence 
of 200 pgiml mAb C6.7. Alternately, SMC were prein- 
cubated with 10 pg/ml cycloheximide to inhibit the in- 
duction of TSP synthesis following exposure to PDGF. 
Cycloheximide-treated SMC were assayed for migra- 
tion to either TSP or PDGF (Fig. 8b). Chemotaxis to 
PDGF was dramatically inhibited, P < 0.01, in the 
presence of cycloheximide. Furthermore, chemotaxis in 
response to TSP was also reduced in cycloheximide- 
treated SMC, P < 0.05, but to a much lesser extent. 
These experiments indicated that cell surface-associ- 
ated TSP is essential for SMC chemotaxis to PDGF, 
and that PDGF stimulates SMC motility indirectly, 
through induction of TSP expression which serves as an 
autocrine motility factor. 
DISCUSSION 
A critical event in the early stages of atherosclerotic 
lesion development is the migration of SMC from the 
media into the intima of the blood vessel wall. In the 
present study, we investigated the role of TSP in SMC 
migration and found that TSP was a potent mediator of 
SMC migration. In comparison with concentrations of 
bFGF or PDGF-BB which resulted in maximal levels of 
migration, TSP elicited a 40% greater migratory re- 
sponse. Of particular interest was the finding that sub- 
optimal concentrations of TSP potentiated SMC migra- 
tion to PDGF. SMC migration to the combination of 
TSP and PDGF was greater than the maximal response 
observed to PDGF alone, suggesting that interactions 
of growth factors with ECM molecules may accelerate 
responses initiated by one or the other. Further investi- 
gation demonstrated that TSP is an  autocrine motility 
factor for vascular SMC and is essential for PDGF- 
mediated motility. The availability of TSP at sites of 
vascular damage and inflammation, both kinetically 
and spatially, correlates with early events after injury 
(Raugi et al., 1990; Botney et al., 1992) and suggests 
that TSP may be an important modulator of these pro- 
cesses. Furthermore, since PDGF expression is also an 
early response to vascular injury (Walker et al., 19861, 
these results emphasize the complex interactions that 
can be expected to influence SMC behavior following 
vascular damage. 
The interaction of TSP with SMC has been previously 
studied with respect to proliferation (Majack et al., 
1986, 1988). TSP was demonstrated to be essential for 
SMC proliferation in response to PDGF, an effect pre- 
sumably involving the HBD since heparin was inhibi- 
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Fig. 7. TSP potentiation of SMC migration to PDGF is inhibited by 
anti-TSP mAb C6.7. a: mAb C6.7 inhibition of TSP potentiation of 
PDGF-mediated SMC migration is dose dependent. b TSP proteolytic 
fragments are not able to potentiate SMC migration to PDGF. SMC 
( 3  x 104/well) were placed into the upper wells of modified Boyden 
chambers. TSP was preincubated in the presence or absence of anti- 
TSP mAbs (200 pg/ml except as indicated) for 30 minutes at 37°C 
before being added to the lower wells of the chamber along with PDGF 
(10 ngiml). Alternatively, PDGF (10 ngiml) and TSP or TSP prote- 
tory. In contrast, we have shown that the HBD plays a 
facilitative rather than essential role in mediating 
SMC migration. The 140 kD domain mediated SMC 
migration to intact TSP, as shown by inhibition in the 
presence of mAb C6.7, but its potency was halved when 
migration was assessed to 140K alone. Only when the 
HBD and 140K were combined did SMC migration 
reach levels seen with intact TSP. These results sug- 
gested that the HBD does not directly mediate SMC 
migration, but facilitates migration, perhaps by influ- 
encing the conformation of 140K. The importance of 
conformation in TSP-mediated SMC migration was fur- 
ther supported by studies involving anti-TSP mAbs and 
heparin. Heparin by itself only slightly inhibited SMC 
migration to either intact TSP or 140K. mAb (26.7 also 
partially inhibited SMC migration to 140K. However, 
heparin in conjunction with mAb C6.7 inhibited migra- 
tion to 140K almost completely. These results suggest 
that a conformationally sensitive site on the 140 kD 
fragment, possibly the secondary heparin-binding site 
lying within the type I repeats of TSP (Guo et al., 
1992a,b), binds heparin and plays a role in SMC migra- 
tion. Exposure of a cryptic heparin-binding site within 
the 140K fragment upon proteolytic cleavage has been 
previously observed, and may have physiological impli- 
cations since cellular responses to intact vs. proteolyzed 
matrix proteins are often distinct (Guo et al., 1992a; 
Chelberg et  al., 1989). Although the evidence argues 
against a role for the HBD interacting with heparan 
sulfate proteoglycans in mediating SMC migration, the 
data suggest that cell surface proteoglycans may inter- 
act with the heparin-binding site in 140K. Interest- 
ingly, heparin inhibits TSP-mediated potentiation of 
SMC proliferation to EGF and shifts TSP localization 
from the SMC cell surface into the media (Majack et al., 
1986, 1988). Such modulation of TSP expression pat- 
terns, rather than inhibiting SMC motility, could accel- 
erate SMC migration by raising concentrations of solu- 
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olytic fragments (50 nM) were added to the lower wells. Assays were 
carried out for 6 hours at 37°C. The number of migrating SMC was 
scored as  described in Materials and Methods with triplicate filters 
prepared for each treatment. Five high power ( ~ 4 0 0 )  fields were 
scored for each filter and values shown represent the mean '% 
control i S.E.M. Control values represent SMC migration to the mix- 
ture of PDGF and 50 nM TSP; 105.1 ? 8.8 SMC/400x field in a,  and 
106.8 -t 10.0 SMCI400x field in b. *P < 0.005. 
Thus, TSP could differentially affect SMC responses 
depending on changes in TSP-SMC association and 
TSP functional domains involved. 
Adhesion of SMC to TSP is mediated through the 
a,& vitronectin receptor (Lawler e t  al., 1988). We have 
demonstrated a role for an a,-containing integrin, but 
not a,p3, in SMC migration to TSP. Lack of inhibition 
of SMC migration with either or p3 antibodies sug- 
gested that the SMC receptor mediating migration is 
neither the a,P3 receptor involved in SMC adhesion 
(Lawler et al., 1988) nor the a,pl receptor involved in 
adhesion of epithelial cells to vitronectin (Bodary and 
McLean, 1990). Neurite outgrowth of embryonic chick 
retinal neurons on TSP was inhibited by antibodies to  
a, (Neugebauer et al., 19911, implicating a,-containing 
integrins in this specialized form of migration. Overall 
these data indicate the presence of multiple functional 
receptors on SMC surfaces that  interact with TSP, in- 
cluding heparan sulfate proteoglycans in TSP-depen- 
dent SMC proliferation and a, integrins in TSP-medi- 
ated SMC motility. 
Although the effects of PDGF on SMC migration 
have been extensively studied, little is known about the 
interaction of growth factors with accessory molecules 
important in cell migration, such as  components of the 
ECM. Expression of TSP and PDGF a t  sites of vascular 
injury is linked both functionally and temporally. 
PDGF treatment of SMC stimulates a rapid, though 
transient, rise in TSP expression (Majack et al., 19851, 
and TSP can also be derived from activation of plate- 
lets, monocytes, fibroblasts, and endothelial cells 
(Mosher, 1990). Sources of PDGF include activated 
platelets, monocytes, endothelial cells, and SMC them- 
selves (Ross, 1986). Both TSP and PDGF are expressed 
by similar cell types, and with similar kinetics after cell 
activation, thus leading to their colocalization a t  sites 
of vascular damage. Based on this evidence, we investi- 
gated the effect of suboptimal concentrations of TSP on 
PDGF-mediated SMC migration. Our data support a 
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Fig. 8. TSP synthesis and cell surface association are essential for 
SMC migration to PDGF. a: Anti-TSP mAb C6.7 inhibited SMC 
chemotaxis to PDGF. b: Treatment of SMC with cycloheximide (CHX) 
inhibited SMC chemotaxis to PDGF. SMC were preincubated with 
either mAb C6.7 (30 minutes, concentration as indicated) or cyclohex- 
imide (16 hours, 10 pgiml) before being placed into the upper wells of 
the chemotaxis chamber. In addition, mAb C6.7 or cycloheximide was 
present throughout the assay. TSP (1 pM) or PDGF (0.3 nM), as indi- 
cated, was placed into the lower wells and the chamber was incubated 
for 6 hours at  37°C. The number of migrating SMC was scored in 
triplicate as described in Materials and Methods. Five high power 
( ~ 4 0 0 )  fields were scored for each filter and values represent the mean 
% control % S.E.M. 
role for TSP in the potentiation of PDGF-mediated mi- 
gration. The effect was dose dependent, specific for 
TSP, and mediated by a site in the 140 kD domain. 
Maximal potentiation was observed between 50 and 
100 nM TSP, a log-fold lower than the concentrations 
necessary for maximal stimulation of SMC migration 
by TSP alone. Additionally, 50 nM TSP has been shown 
to stimulate S6 kinase and phosphatidylinositol turn- 
over in SMC (Scott-Burden et al., 19881, indicating that  
TSP elicits physiologically relevant responses within 
this concentration range. 
SMC migration to the combination of TSP and PDGF 
was completely inhibited by mAb C6.7, an unlikely 
result if TSP and PDGF were acting independently. 
Alternate scenarios include a functional linkage be- 
tween TSP and PDGF receptors on the SMC surface or 
a specific bimolecular complex formed by TSP and 
PDGF. Raines et al. (1992) demonstrated binding of 
PDGF to the ECM protein SPARC which inhibited 
PDGF binding to its receptor, but failed to detect PDGF 
binding to TSP under similar conditions. We investi- 
gated the possible interaction of TSP with PDGF by 
determining if radiolabeled TSP coimmunoprecipitated 
with PDGF, and found no evidence for a specific inter- 
action (data not shown). Therefore, we took two alter- 
nate approaches in elucidating a mechanism for poten- 
tiation of SMC chemotaxis in the presence of both 
PDGF and TSP. Since anti-TSP mAbs have been shown 
to disrupt the association of TSP with the SMC surface 
(Majack et al., 19881, we preincubated SMC with mAb 
C6.7 before assessing migration to PDGF. In the pres- 
ence of mAb C6.7, SMC were unable to migrate to 
PDGF, indicating that cell surface-associated TSP is 
critical in this process. Additionally, it was evident that 
PDGF would induce de novo TSP synthesis during the 6 
hour assay period (Majack et al., 1987). By using cyclo- 
heximide to inhibit de novo protein synthesis, we inves- 
tigated the importance of TSP in SMC motility to  
PDGF. Our results demonstrated that TSP is an essen- 
tial autocrine motility factor for SMC; i.e., PDGF stim- 
ulates motility indirectly through the induction of TSP 
synthesis. Thus, inhibition of either TSP synthesis or 
TSP-SMC interactions resulted in a diminished SMC 
migratory response. Although the combination of 
PDGF-AA and bFGF has been demonstrated to potenti- 
ate SMC proliferation (Majack et  al., 1990), the mecha- 
nism of action involved remains unclear. Similarly, the 
pathway(s) through which TSP facilitates EGF-depen- 
dent SMC proliferation (Majack et al., 1986) has not 
been identified. Overall, the potentiation of growth fac- 
tor-mediated functional responses by TSP, such as SMC 
migration and proliferation, reinforces the autocrine 
nature of TSPs interactions with SMC. 
Recently, a more comprehensive picture of the role of 
TSP in SMC behavior has begun to emerge. No longer 
defined only as a component of the ECM, TSP has been 
shown to exert pleiotropic effects on SMC. First, TSP is 
an  immediate-early response gene activated following 
PDGF treatment of SMC (Majack et al., 1987). Second, 
TSP promotes adhesion of SMC (Lawler et al., 1988). 
Third, TSP functions as a n  autocrine growth factor, 
potentiating EGF- and PDGF-mediated SMC prolifera- 
tion (Majack et al., 1986, 1988). Fourth, we have dem- 
onstrated that TSP is a potent modulator of SMC mi- 
gration and is essential in SMC migration to PDGF. In 
vivo, TSP has been localized to atherosclerotic plaques, 
regions of SMC migration and proliferation (Botney et 
al., 1992; Wight et al., 1985). Furthermore, evidence 
that endothelial cell adhesion and proliferation are in- 
hibited by TSP (Lahav, 1988; Bagavandoss and Wilks, 
1990) suggests that TSP may play a dual role in athero- 
sclerosis; promoting SMC adhesion, migration, and pro- 
liferation in the vascular intima while preventing 
endothelial cells from doing the same. Thus, TSP influ- 
ences several aspects of SMC physiology important in 
the early events preceding the development of an ath- 
erosclerotic lesion. By understanding the molecular 
switches controlling these pathways in greater detail, 
the molecular targets most amenable to early and effec- 
tive therapeutic intervention can be identified. 
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